Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK MHRA's (Medicines and Healthcare products Regulatory Authority) DES (Device Evaluation Service) updates radiology reviews

This article was originally published in Clinica

Executive Summary

The Device Evaluation Service (DES) of the UK's Medicines and Healthcare products Regulatory Authority (MHRA) has published the third edition of Comparative specifications of single plane cardiovascular imaging systems. It covers the General Electric Innova 2000, Philips Integris Allura Xper FD10, MIS Shimadzu Angiospeed HF, Siemens Axiom Artis dFC, and Toshiba's Infinix CCi and Cci-FPD, among others. The DES' comparative specifications reports aim to assist prospective purchasers in the selection of equipment appropriate to their requirements, but do not contain evaluation data; the DES can supply the related evaluation reports upon request (des@mhra.gsi.gov.uk). As part of its ongoing programme of evaluations of direct digital radiography systems, the DES has published a Digital imaging systems for general radiography report on the General Electric Medical Systems Revolution XR/d2.

You may also be interested in...



Butterfly Network’s CEO Sees Blank Check Deal As Path To ‘Democratize’ Portable Imaging Platform

Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.

Regenerative Medicine Comes Of Age – In The Age Of COVID-19

Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.

With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says

As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.

Topics

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel